Published in Circ Res on June 25, 1999
eNOS, metabolic syndrome and cardiovascular disease. Trends Endocrinol Metab (2009) 2.04
Antiphospholipid antibodies promote leukocyte-endothelial cell adhesion and thrombosis in mice by antagonizing eNOS via β2GPI and apoER2. J Clin Invest (2010) 1.77
Thrombospondin-1 stimulates platelet aggregation by blocking the antithrombotic activity of nitric oxide/cGMP signaling. Blood (2007) 1.73
Cardiovascular roles of nitric oxide: a review of insights from nitric oxide synthase gene disrupted mice. Cardiovasc Res (2008) 1.53
Regulation of platelet granule exocytosis by S-nitrosylation. Proc Natl Acad Sci U S A (2005) 1.52
Antiinflammatory activity of soluble guanylate cyclase: cGMP-dependent down-regulation of P-selectin expression and leukocyte recruitment. Proc Natl Acad Sci U S A (2004) 1.26
Endothelial nitric oxide synthase transgenic models of endothelial dysfunction. Pflugers Arch (2010) 1.22
Role of reactive oxygen and nitrogen species in the vascular responses to inflammation. Free Radic Biol Med (2011) 1.17
A modest decrease in endothelial NOS in mice comparable to that associated with human NOS3 variants exacerbates diabetic nephropathy. Proc Natl Acad Sci U S A (2011) 1.10
Nitric oxide insufficiency and atherothrombosis. Histochem Cell Biol (2004) 1.08
Identification, regulation and role of tissue inhibitor of metalloproteinases-4 (TIMP-4) in human platelets. Br J Pharmacol (2002) 1.08
S-nitrosothiols modulate G protein-coupled receptor signaling in a reversible and highly receptor-specific manner. BMC Cell Biol (2005) 1.07
Endothelial cell-specific liver kinase B1 deletion causes endothelial dysfunction and hypertension in mice in vivo. Circulation (2014) 1.05
Nitric oxide regulation of protein trafficking in the cardiovascular system. Cardiovasc Res (2007) 1.04
Hydrogen peroxide decreases endothelial nitric oxide synthase promoter activity through the inhibition of AP-1 activity. Am J Physiol Lung Cell Mol Physiol (2008) 1.02
Effect of blood nitrite and nitrate levels on murine platelet function. PLoS One (2013) 1.00
Akt signaling in platelets and thrombosis. Expert Rev Hematol (2010) 0.99
Signaling-mediated functional activation of inducible nitric-oxide synthase and its role in stimulating platelet activation. J Biol Chem (2008) 0.92
Transcriptional targeting of tumor endothelial cells for gene therapy. Adv Drug Deliv Rev (2009) 0.91
Decreased production of neuronal NOS-derived hydrogen peroxide contributes to endothelial dysfunction in atherosclerosis. Br J Pharmacol (2011) 0.90
Platelet aggregation responses are critically regulated in vivo by endogenous nitric oxide but not by endothelial nitric oxide synthase. Br J Pharmacol (2009) 0.88
Deficient eNOS phosphorylation is a mechanism for diabetic vascular dysfunction contributing to increased stroke size. Stroke (2013) 0.87
Improvement of vascular function by acute and chronic treatment with the GPR30 agonist G1 in experimental diabetes mellitus. PLoS One (2012) 0.87
Blockade of the purinergic P2Y12 receptor greatly increases the platelet inhibitory actions of nitric oxide. Proc Natl Acad Sci U S A (2013) 0.86
eNOS phosphorylation on serine 1176 affects insulin sensitivity and adiposity. Biochem Biophys Res Commun (2013) 0.85
C-type natriuretic peptide (CNP): cardiovascular roles and potential as a therapeutic target. Curr Pharm Des (2010) 0.85
Partial eNOS deficiency causes spontaneous thrombotic cerebral infarction, amyloid angiopathy and cognitive impairment. Mol Neurodegener (2015) 0.84
Platelet-derived NO slows thrombus growth on a collagen type III surface. Thromb J (2004) 0.83
Hydrogen peroxide decreases endothelial nitric oxide synthase promoter activity through the inhibition of Sp1 activity. DNA Cell Biol (2009) 0.83
Effects of Physical (In)activity on Platelet Function. Biomed Res Int (2015) 0.82
Refinement, reduction and replacement approaches to in vivo cardiovascular research. Br J Pharmacol (2010) 0.79
Platelet redox balance in diabetic patients with hypertension improved by n-3 fatty acids. Diabetes Care (2012) 0.78
Administration of pigment epithelium-derived factor prolongs bleeding time by suppressing plasminogen activator inhibitor-1 activity and platelet aggregation in rats. Clin Exp Med (2008) 0.78
Redox Pioneer: Professor Joseph Loscalzo. Antioxid Redox Signal (2010) 0.77
Gene regulation in the vascular endothelium: why epigenetics is important for the kidney. Semin Nephrol (2012) 0.77
DNA Damage: A Main Determinant of Vascular Aging. Int J Mol Sci (2016) 0.77
Inherited dysfunctional nitric oxide signaling and the pathobiology of atherothrombotic disease. Circ Res (2014) 0.76
Inhibition of nitric oxide and antiphospholipid antibody-mediated thrombosis. Curr Rheumatol Rep (2013) 0.76
Fibroblast growth factor 21 deletion aggravates diabetes-induced pathogenic changes in the aorta in type 1 diabetic mice. Cardiovasc Diabetol (2015) 0.75
Nitric oxide insufficiency and arterial thrombosis. Trans Am Clin Climatol Assoc (2000) 0.75
Calcium channel blockers increase the amount of nitrite production in rabbits without decreasing the responsiveness of platelets to collagen. Clin Exp Med (2008) 0.75
A redox-based mechanism for the neuroprotective and neurodestructive effects of nitric oxide and related nitroso-compounds. Nature (1993) 8.29
Biochemistry of nitric oxide and its redox-activated forms. Science (1992) 7.72
Endothelial cells in physiology and in the pathophysiology of vascular disorders. Blood (1998) 7.70
Homocysteine and atherothrombosis. N Engl J Med (1998) 6.70
Nitric oxide synthase modulates angiogenesis in response to tissue ischemia. J Clin Invest (1998) 5.95
S-nitrosylation of proteins with nitric oxide: synthesis and characterization of biologically active compounds. Proc Natl Acad Sci U S A (1992) 5.37
Effects of cerebral ischemia in mice deficient in neuronal nitric oxide synthase. Science (1994) 5.15
Predominant role of endothelial nitric oxide synthase in vascular endothelial growth factor-induced angiogenesis and vascular permeability. Proc Natl Acad Sci U S A (2001) 3.88
Nitric oxide circulates in mammalian plasma primarily as an S-nitroso adduct of serum albumin. Proc Natl Acad Sci U S A (1992) 3.72
Behavioural abnormalities in male mice lacking neuronal nitric oxide synthase. Nature (1995) 3.15
Accelerated atherosclerosis, aortic aneurysm formation, and ischemic heart disease in apolipoprotein E/endothelial nitric oxide synthase double-knockout mice. Circulation (2001) 3.01
Impaired metabolic modulation of alpha-adrenergic vasoconstriction in dystrophin-deficient skeletal muscle. Proc Natl Acad Sci U S A (1998) 3.00
The biology of nitrogen oxides in the airways. Am J Respir Crit Care Med (1994) 2.90
Enlarged infarcts in endothelial nitric oxide synthase knockout mice are attenuated by nitro-L-arginine. J Cereb Blood Flow Metab (1996) 2.78
Impaired vasodilation of forearm resistance vessels in hypercholesterolemic humans. J Clin Invest (1990) 2.69
The platelet function defect of cardiopulmonary bypass. Blood (1993) 2.63
Consequences of GATA-1 deficiency in megakaryocytes and platelets. Blood (1999) 2.61
Localized high-resolution proton NMR spectroscopy using stimulated echoes: initial applications to human brain in vivo. Magn Reson Med (1989) 2.51
Adverse vascular effects of homocysteine are modulated by endothelium-derived relaxing factor and related oxides of nitrogen. J Clin Invest (1993) 2.47
Aspirin. Circulation (2000) 2.26
A mutation in the Norrie disease gene (NDP) associated with X-linked familial exudative vitreoretinopathy. Nat Genet (1993) 2.23
Myocardial ischemia-reperfusion injury is exacerbated in absence of endothelial cell nitric oxide synthase. Am J Physiol (1999) 2.13
Effects of targeted neuronal nitric oxide synthase gene disruption and nitroG-L-arginine methylester on the threshold for isoflurane anesthesia. Anesthesiology (1995) 2.13
A noninvasive method of predicting pulmonary-capillary wedge pressure. N Engl J Med (1992) 2.12
Structure of pre-pro-von Willebrand factor and its expression in heterologous cells. Nature (1987) 2.04
Reduced brain edema and infarction volume in mice lacking the neuronal isoform of nitric oxide synthase after transient MCA occlusion. J Cereb Blood Flow Metab (1996) 2.01
End-of-study safety, immunogenicity, and efficacy of quadrivalent HPV (types 6, 11, 16, 18) recombinant vaccine in adult women 24-45 years of age. Br J Cancer (2011) 1.96
Endothelial dysfunction in a murine model of mild hyperhomocyst(e)inemia. J Clin Invest (2000) 1.94
Noninvasive differentiation of tumors with use of localized H-1 MR spectroscopy in vivo: initial experience in patients with cerebral tumors. Radiology (1989) 1.91
In vivo tracking of platelets: circulating degranulated platelets rapidly lose surface P-selectin but continue to circulate and function. Proc Natl Acad Sci U S A (1996) 1.90
An endothelium-derived hyperpolarizing factor distinct from NO and prostacyclin is a major endothelium-dependent vasodilator in resistance vessels of wild-type and endothelial NO synthase knockout mice. Proc Natl Acad Sci U S A (2000) 1.89
Endothelial nitric oxide synthase limits left ventricular remodeling after myocardial infarction in mice. Circulation (2001) 1.89
The antiplatelet effects of ticlopidine and clopidogrel. Ann Intern Med (1998) 1.88
Cellular adhesion molecules and atherogenesis. Am J Med (1999) 1.88
Increased acid-sensing ion channel ASIC-3 in inflamed human intestine. Eur J Gastroenterol Hepatol (2001) 1.87
Flow activates an endothelial potassium channel to release an endogenous nitrovasodilator. J Clin Invest (1991) 1.82
Vanilloid receptor 1 immunoreactivity in inflamed human bowel. Lancet (2001) 1.79
Homocyst(e)ine decreases bioavailable nitric oxide by a mechanism involving glutathione peroxidase. J Biol Chem (1997) 1.77
Neuroprotection mediated by changes in the endothelial actin cytoskeleton. J Clin Invest (2000) 1.76
The oxidant stress of hyperhomocyst(e)inemia. J Clin Invest (1996) 1.76
Regulation of vascular endothelial growth factor in cardiac myocytes. Circ Res (1995) 1.75
Resistance to neurotoxicity in cortical cultures from neuronal nitric oxide synthase-deficient mice. J Neurosci (1996) 1.73
Leukocyte-endothelial cell interactions in nitric oxide synthase-deficient mice. Am J Physiol (1999) 1.72
Sustained pulmonary hypertension and right ventricular hypertrophy after chronic hypoxia in mice with congenital deficiency of nitric oxide synthase 3. J Clin Invest (1998) 1.72
Neuronal pathfinding is abnormal in mice lacking the neuronal growth cone protein GAP-43. Cell (1995) 1.71
The pulmonary circulation of homozygous or heterozygous eNOS-null mice is hyperresponsive to mild hypoxia. J Clin Invest (1999) 1.71
Interaction of genetic deficiency of endothelial nitric oxide, gender, and pregnancy in vascular response to injury in mice. J Clin Invest (1998) 1.65
Paradoxical embolism: clinical presentation, diagnostic strategies, and therapeutic options. Am Heart J (1986) 1.64
Pulmonary vasoconstriction and hypertension in mice with targeted disruption of the endothelial nitric oxide synthase (NOS 3) gene. Circ Res (1997) 1.63
Genetic deficiency of inducible nitric oxide synthase reduces atherosclerosis and lowers plasma lipid peroxides in apolipoprotein E-knockout mice. Circulation (2001) 1.63
Long-term potentiation is reduced in mice that are doubly mutant in endothelial and neuronal nitric oxide synthase. Cell (1996) 1.61
N-acetylcysteine potentiates platelet inhibition by endothelium-derived relaxing factor. Circ Res (1989) 1.58
N-Acetylcysteine potentiates inhibition of platelet aggregation by nitroglycerin. J Clin Invest (1985) 1.57
Reduced severity of oxygen-induced retinopathy in eNOS-deficient mice. Invest Ophthalmol Vis Sci (2001) 1.57
Regulation of tissue factor expression in human microvascular endothelial cells by nitric oxide. Circulation (2000) 1.56
Endothelial NOS and the blockade of LTP by NOS inhibitors in mice lacking neuronal NOS. Science (1994) 1.56
The antiplatelet effects of organic nitrates and related nitroso compounds in vitro and in vivo and their relevance to cardiovascular disorders. J Am Coll Cardiol (1991) 1.55
Identification and characterization of three new promoter/operators from Corynebacterium diphtheriae that are regulated by the diphtheria toxin repressor (DtxR) and iron. Infect Immun (1997) 1.55
Acetylcholine-induced relaxation in blood vessels from endothelial nitric oxide synthase knockout mice. Br J Pharmacol (1999) 1.54
nNOS and eNOS modulate cGMP formation and vascular response in contracting fast-twitch skeletal muscle. Physiol Genomics (2000) 1.54
Peroxynitrite-induced rat colitis--a new model of colonic inflammation. Gastroenterology (1993) 1.53
In vivo transfer of nitric oxide between a plasma protein-bound reservoir and low molecular weight thiols. J Clin Invest (1994) 1.53
Heparin causes platelet dysfunction and induces fibrinolysis before cardiopulmonary bypass. Ann Thorac Surg (1995) 1.51
Cell-surface protein disulfide isomerase catalyzes transnitrosation and regulates intracellular transfer of nitric oxide. J Clin Invest (1999) 1.49
Proton MR spectroscopy of the brain: clinically useful information obtained in assessing CNS diseases in children. AJR Am J Roentgenol (1996) 1.47
Randomized trial of an oral platelet glycoprotein IIb/IIIa antagonist, sibrafiban, in patients after an acute coronary syndrome: results of the TIMI 12 trial. Thrombolysis in Myocardial Infarction. Circulation (1998) 1.47
Mevastatin, an HMG-CoA reductase inhibitor, reduces stroke damage and upregulates endothelial nitric oxide synthase in mice. Stroke (2001) 1.47
Flow stimulates endothelial cells to release a nitrovasodilator that is potentiated by reduced thiol. Am J Physiol (1990) 1.47
In vivo biotinylation demonstrates that reticulated platelets are the youngest platelets in circulation. Exp Hematol (1995) 1.45
NO forms an adduct with serum albumin that has endothelium-derived relaxing factor-like properties. J Clin Invest (1993) 1.44
Homocysteine, oxidative stress, and vascular disease. Hosp Pract (1995) (1997) 1.44
Localized proton NMR spectroscopy in different regions of the human brain in vivo. Relaxation times and concentrations of cerebral metabolites. Magn Reson Med (1989) 1.43
Contribution of nitric oxide synthases 1, 2, and 3 to airway hyperresponsiveness and inflammation in a murine model of asthma. J Exp Med (1999) 1.38
Effects of race and hypertension on flow-mediated and nitroglycerin-mediated dilation of the brachial artery. Hypertension (2001) 1.38
Mechanisms of reduced striatal NMDA excitotoxicity in type I nitric oxide synthase knock-out mice. J Neurosci (1997) 1.38
Relaxation of human bronchial smooth muscle by S-nitrosothiols in vitro. J Pharmacol Exp Ther (1994) 1.36
Endothelial dysfunction in pulmonary hypertension. N Engl J Med (1992) 1.36
Neuronal constitutive nitric oxide synthase is involved in murine enteric inhibitory neurotransmission. J Clin Invest (1996) 1.35
Overexpression of cellular glutathione peroxidase rescues homocyst(e)ine-induced endothelial dysfunction. Proc Natl Acad Sci U S A (2001) 1.34
Simvastatin exerts both anti-inflammatory and cardioprotective effects in apolipoprotein E-deficient mice. Circulation (2001) 1.34
Inhibition of neointimal proliferation in rabbits after vascular injury by a single treatment with a protein adduct of nitric oxide. J Clin Invest (1995) 1.32
Hypertension does not account for the accelerated atherosclerosis and development of aneurysms in male apolipoprotein e/endothelial nitric oxide synthase double knockout mice. Circulation (2001) 1.31
Lysozyme and RNases as anti-HIV components in beta-core preparations of human chorionic gonadotropin. Proc Natl Acad Sci U S A (1999) 1.30
MAP 30: a new inhibitor of HIV-1 infection and replication. FEBS Lett (1990) 1.30
Decreased platelet inhibition by nitric oxide in two brothers with a history of arterial thrombosis. J Clin Invest (1996) 1.29
Antiplatelet properties of protein S-nitrosothiols derived from nitric oxide and endothelium-derived relaxing factor. Arterioscler Thromb (1993) 1.28
Nitric oxide released from activated platelets inhibits platelet recruitment. J Clin Invest (1997) 1.28
Inhibition of fibrinogen binding to human platelets by S-nitroso-N-acetylcysteine. J Biol Chem (1990) 1.28
ACh dilates pial arterioles in endothelial and neuronal NOS knockout mice by NO-dependent mechanisms. Am J Physiol (1996) 1.26
S-nitrosylation of tissue-type plasminogen activator confers vasodilatory and antiplatelet properties on the enzyme. Proc Natl Acad Sci U S A (1992) 1.26
Modulation of mouse cardiac function in vivo by eNOS and ANP. Am J Physiol Heart Circ Physiol (2000) 1.25
Nitric oxide contributes to vascular smooth muscle relaxation in contracting fast-twitch muscles. Physiol Genomics (2001) 1.25
S-Transnitrosation reactions are involved in the metabolic fate and biological actions of nitric oxide. J Pharmacol Exp Ther (1998) 1.25
Proton magnetic resonance spectroscopy in patients with glial tumors: a multicenter study. J Neurosurg (1996) 1.24
alpha-tocopherol inhibits aggregation of human platelets by a protein kinase C-dependent mechanism. Circulation (1996) 1.24
Native conformation of human von Willebrand protein. Analysis by electron microscopy and quasi-elastic light scattering. J Biol Chem (1985) 1.24
Focal ischemic preconditioning induces rapid tolerance to middle cerebral artery occlusion in mice. J Cereb Blood Flow Metab (1999) 1.23